“Although there was no overall increase in NAA in manic adolescents following 28 days of treatment with olanzapine, olanzapine remitters (N=11, 58%) exhibited a greater increase in medial ventral prefrontal NAA compared with nonremitters (N=8, 42%, p=0.006).”